Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Caroline Benson and Colin Williams to Chair the PM Society from February 2020

January 31, 2020 |  

For the first time both industry and agencies will be equally represented as the PM Society appoints a joint chair.

- PMLiVE

For the first time both industry and agencies will be equally represented as the PM Society appoints a joint chair. Colin Williams who has spent the last 20 years working in pharma digital marketing and is currently in the GSK Global team comes with a wealth of industry experience as well as a stint agency side and Caroline Benson, co-Founder and Director of Cuttsy and Cuttsy who has also spent over 20 years agency side with the last nine years building her own agency, will be chairing the society for the next two years.

The two of them are long time supporters of the PM Society, Colin has been involved in the Digital Awards and Digital interest group lead since their inception and Caroline has been the Patient Engagement interest group lead for the last couple of years.

In part of a statement from Caroline she said ‘It’s been a very interesting couple of months since Colin and I were approached to chair the society. We have had many discussions on what we would like to achieve and surprised ourselves on how similar our thoughts are, we definitely want to make a difference over the next couple of years. We are committed to giving back as well as championing resilience and mental health, for me personally, changing the way agencies work for the better of their teams, through flexible working practices and no more long hour medal of honour mentalities, is a great place to start.’

Colin Williams added: ‘The PM Society has a rich history and as a non for profit organisation we have an amazing amount of support from the industry and we want to put it to best use and run a marketing-driven society that provides education and support to it’s members and affiliates. I’ve personally benefitted in so many ways from being involved with the society, and I know others who have shared similar experiences would say the same, but I also know there are a lot of people in our industry who don’t know about us, and I’m passionate about extending our reach as far across the pharma industry as we can, so more people know what we do, get involved in helping us and get their own benefits in the process.’

This content was provided by Cuttsy + Cuttsy

Company Details

Cuttsy and Cuttsy Logo

Cuttsy + Cuttsy

Email
Website

 Latest Content from  Cuttsy + Cuttsy 

From text to context: Helping patients see side effects clearly

Discover how thoughtful design, clear language, and structured visuals can transform overwhelming side effect information into accessible, actionable insights for patients in our latest Health Literacy series.

Why patient engagement must come first in rare disease trials

Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients' lives to build trust and improve outcomes.

New Cuttsy+Cuttsy research shows why site support matters more than ever

Cuttsy+Cuttsy's upcoming report, 'The site factor: Where protocol meets practice in clinical trials', delves into the critical role of site staff in clinical research, offering insights into their daily challenges,...

Cuttsy+Cuttsy becomes employee owned

Cuttsy+Cuttsy announces its transition to employee ownership, celebrating 15 years of prioritising clients, patients, and its team while continuing under the leadership of founders Caroline Benson and Mathew Cutts.

Clinical research in 2026: The trends shaping tomorrow

Discover the key trends shaping clinical research in 2026, from patient-centric approaches to empowering site staff and fostering stronger human connections.

From overwhelming to actionable: Bringing lifestyle guidance to life

Discover how clear communication and health literacy principles can transform complex patient materials into simple, engaging, and empowering health information.

Behind the scenes: why we created ‘The participation equation’

Go behind the scenes of The participation equation – our call to put people, not just data, at the heart of clinical research.

Cuttsy+Cuttsy launches R:SQD – a new way to predict and improve trial success

Cuttsy+Cuttsy has launched R:SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and improve participant engagement and trial outcomes.

New report, The participation equation, uncovers key drivers of patient engagement in clinical trials

Cuttsy+Cuttsy’s new report, The participation equation, uncovers what drives patient engagement and retention in modern clinical trials through insights from over 700 participants and industry experts.

Why patients drop out of weight management trials and what you can do about it

Discover the key barriers to retention in obesity and weight-management trials and explore actionable, patient-centered strategies to improve engagement, outcomes, and data reliability.